HUTCHMED (China) (HCM) Enterprise Value Growth (1y) (2015 - 2025)
HUTCHMED (China) (HCM) Enterprise Value Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100.00% |
| Jun 30, 2025 | -70.98% |
| Dec 31, 2024 | -6,542,348.44% |
| Jun 30, 2024 | 5.69% |
| Dec 31, 2023 | 2,227.31% |
| Jun 30, 2023 | -8.28% |
| Dec 31, 2022 | 37.24% |
| Jun 30, 2022 | 16.00% |
| Dec 31, 2021 | 71.71% |
| Jun 30, 2021 | -259.86% |
| Dec 31, 2020 | -100.39% |
| Jun 30, 2020 | -20.71% |
| Dec 31, 2019 | 21.80% |
| Jun 30, 2019 | 28.42% |
| Dec 31, 2018 | 17.12% |
| Jun 30, 2018 | -227.82% |
| Dec 31, 2017 | -299.31% |
| Jun 30, 2017 | 11.21% |
| Dec 31, 2016 | -529.54% |
| Dec 31, 2015 | 65.78% |